SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-108392
Filing Date
2021-08-23
Accepted
2021-08-23 09:19:36
Documents
13
Period of Report
2021-08-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2125689d1_8k.htm   iXBRL 8-K 25386
2 EXHIBIT 3.1 tm2125689d1_ex3-1.htm EX-3.1 4655
  Complete submission text file 0001104659-21-108392.txt   209176

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hepa-20210820.xsd EX-101.SCH 3182
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hepa-20210820_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hepa-20210820_pre.xml EX-101.PRE 22708
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2125689d1_8k_htm.xml XML 3809
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 211195512
SIC: 2834 Pharmaceutical Preparations